Michael A. Harding
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 5%
- Protein Kinase Regulation and GTPase Signaling
- Renal and related cancers
- Sphingolipid Metabolism and Signaling
- Epigenetics and DNA Methylation
Papers in
-
- Metabolism, Diabetes, and Cancer 3
- Mechanisms of cancer metastasis 3
- Renal and related cancers 3
-
- Cancer, Lipids, and Metabolism 4
- Cancer, Hypoxia, and Metabolism 4
- Co-authors
- Dan Theodorescu (21 shared papers)John J Gildea (8 shared papers)James P. Calvet (4 shared papers)Vincent H. Gattone (3 shared papers)Henry F. Frierson (5 shared papers)Glen K. Andrews (2 shared papers)Eileen D. Adamson (2 shared papers)M. Jabed Seraj (3 shared papers)
- Journals
- Molecular and Cellular Biology (2 papers)Cancer Research (2 papers)Molecular Pharmacology (2 papers)Kidney International (2 papers)Oncogene (2 papers)
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Michael A. Harding
30 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 95
- Cancer Research 356
- Molecular Biology 1.4k
- Oncology 393
- Cell Biology 228
- Biochemistry 90
Countries citing papers authored by Michael A. Harding
This map shows the geographic impact of Michael A. Harding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Harding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Harding more than expected).
Fields of papers citing papers by Michael A. Harding
This network shows the impact of papers produced by Michael A. Harding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Harding. The network helps show where Michael A. Harding may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael A. Harding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 202 | |
| 2 | RhoGDI2 is an invasion and metastasis suppressor gene in human cancer. | 2002 | 197 |
| 3 | 2000 | 169 | |
| 4 | 1987 | 140 | |
| 5 | 2001 | 122 | |
| 6 | 2012 | 117 | |
| 7 | 2000 | 112 | |
| 8 | 1987 | 104 | |
| 9 | 1991 | 89 | |
| 10 | 2012 | 82 | |
| 11 | 2010 | 75 | |
| 12 | 2004 | 73 | |
| 13 | The role of Ral A in epidermal growth factor receptor-regulated cell motility. | 2002 | 71 |
| 14 | 2000 | 70 | |
| 15 | 2004 | 69 | |
| 16 | 1992 | 55 | |
| 17 | Functional genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method of positional expression profiling. | 2002 | 50 |
| 18 | 2007 | 35 | |
| 19 | 2000 | 25 | |
| 20 | 2001 | 21 |
About Michael A. Harding
Michael A. Harding is a scholar working on Molecular Biology, Cancer Research, Genetics, Surgery and Pulmonary and Respiratory Medicine, having authored 30 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (4 papers), Bladder and Urothelial Cancer Treatments (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Metabolism, Diabetes, and Cancer (3 papers), Genetic and Kidney Cyst Diseases (3 papers), Mechanisms of cancer metastasis (3 papers), Renal and related cancers (3 papers) and Prostate Cancer Treatment and Research (3 papers). The work is most often cited by research in Cancer Research (356 citations), Molecular Biology (1.4k citations), Oncology (393 citations), Cell Biology (228 citations) and Biochemistry (90 citations). Michael A. Harding has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Dan Theodorescu, John J Gildea, James P. Calvet, Vincent H. Gattone, Henry F. Frierson, Glen K. Andrews, Eileen D. Adamson, M. Jabed Seraj, Mark R. Conaway and Christopher A. Moskaluk. Their work appears in journals such as Molecular and Cellular Biology, Cancer Research, Molecular Pharmacology, Kidney International and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.